Home

Baker Bros. Advisors reported a 9.5% stake in Kymera Therapeutics KYMR · 6,666,540 sh · amendment

Trade details

Type
5% stake report
Report
13D · amendment
Stake
9.5%
Last report
No earlier report
Shares held
6,666,540 sh
Class
Common Stock, $0.0001 par value per share
Event date
25/06/26
Filed
25/06/30

9.5% stake

Kymera Therapeutics trades, last 26 weeks

What else happened in Kymera Therapeutics around then

Filed or reported within 30 days of the trade day · 25/05/27~25/07/26

Baker Bros. Advisors's other 5% stake reports

  • Baker Bros. Advisors

    5% stakeKodiak Sciences

    35% stake

    Filed 09/30

  • Baker Bros. Advisors

    5% stakeBeOne Medicines

    7.8% stake

    Filed 09/16

  • Baker Bros. Advisors

    5% stakeIdeaya Biosciences

    5.2% stake

    Filed 08/14

  • Baker Bros. Advisors

    5% stakeRevolution Medicines

    5.3% stake

    Filed 08/14

  • Baker Bros. Advisors

    5% stakeImmatics

    7% stake

    Filed 08/14